FDA Inspection 1191252 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on Nov 16, 2022 in Mesa, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mesa, AZ (United States)